The study involved end-stage oncology patients with no other suitable treatment options.In this Phase Ib study, Pidnarulex (CX-5461) demonstrated acceptable…
(Steady international business growth brought overseas revenue accounting for 62.23% of its core business revenue) SHANGHAI, Sept. 8, 2024 /PRNewswire/…
SINGAPORE, Sept. 8, 2024 /PRNewswire/ -- JST Digital, a global financial services firm specializing in digital assets, today announced that its Singapore subsidiary, JST…
ROCKVILLE, Md. and SUZHOU, China, Sept. 8, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing…